ada guidelines dpp4 and glp-1 Dipeptidyl Peptidase 4 Inhibitors: Novel Therapeutic Agents in the Management of Type II Diabetes Mellitus GLP-1-RA and DPP-4 inhibitors in

Find your match!

Those who discontinued had an increased risk of heart attack and stroke compared to those who remained on treatment.

What began primarily as a treatment for type 2 diabetes has rapidly evolved, showcasing remarkable efficacy in weight management and hinting at much broader therapeutic po

By Anna Greene, PhD, NETRF Chief Scientific Officer Drugs like Ozempic, Wegovy, and Mounjaro, known as GLP-1 receptor agonists, are now widely used to treat type 2 diabetes and obesity

Smaller meals, hydration, slower dose increases, and better timing can often reduce it.

Essential reading for anyone considering GLP-1 for weight loss or diabetes management, ensuring informed decisions for your health